SAN DIEGO, Aug. 5 /PRNewswire-FirstCall/ —ACADIA Pharmaceuticals Inc.(Nasdaq: ACAD), a biopharmaceutical company utilizing innovative science tofuel drug discovery and clinical development of novel treatments for centralnervous system disorders, today announced that it will report second quarter2004 financial results on Wednesday, August 11, 2004, after the U.S. financialmarkets close.
ACADIA will host a conference call and webcast on Wednesday, August 11,2004 at 4:30 p.m. EDT to discuss financial results for the second quarterended June 30, 2004. Uli Hacksell, Ph.D., ACADIA's Chief Executive Officer,will also provide an update on the Company's progress.
The conference call may be accessed by dialing 800-901-5231 forparticipants from the United States or Canada and 617-786-2961 forinternational callers (reference participant passcode 69887488). Theconference call will also be webcast live on ACADIA's website athttp://www.acadia-pharm.com, under the investor relations section, and will bearchived there until August 25, 2004.
About ACADIA Pharmaceuticals
ACADIA Pharmaceuticals is a biopharmaceutical company utilizing innovativescience to fuel drug discovery and clinical development of novel treatmentsfor central nervous system disorders. ACADIA currently has five drug programsin clinical and preclinical development directed at large unmet medical needsand major commercial markets, including Parkinson's disease, schizophrenia,chronic pain, and glaucoma. Using its proprietary drug discovery platform,ACADIA has discovered all of the drug candidates in its product pipeline.ACADIA's corporate headquarters and biological research facilities are locatedin San Diego, California and its chemistry research facilities are located inCopenhagen, Denmark.
For further information, please contact Thomas H. Aasen, Vice Presidentand Chief Financial Officer of ACADIA Pharmaceuticals Inc., +1-858-558-2871.
SOURCE ACADIA Pharmaceuticals, Inc.
08/05/2004
CONTACT: Thomas H. Aasen, Vice President and Chief Financial Officer ofACADIA Pharmaceuticals Inc., +1-858-558-2871
Web site: http://www.acadia-pharm.com